Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) has taken a significant step in advancing cancer treatment by signing a collaboration and license agreement with Genentech,...
Genentech
Genentech, part of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), is making headway in the race to develop new treatments for multiple sclerosis (MS)....
Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and its U.S. biotech subsidiary, Genentech, are making a significant move into the American Southeast, announcing plans for...
